|
51 |
Functional consultation and exercises improve grip strength in osteoarthritis of the hand – a randomised controlled trial
Enthalten in Arthritis Research & Therapy Bd. 20, 9.11.2018, Nr. 1, date:12.2018: 1-11
|
|
|
|
52 |
Gait changes precede overt arthritis and strongly correlate with symptoms and histopathological events in pristane-induced arthritis
Enthalten in Arthritis Research & Therapy Bd. 12, 11.3.2010, Nr. 2, date:4.2010: 1-10
|
|
|
|
53 |
Golimumab in patients with active rheumatoid arthritis after treatment with tumor necrosis factor α inhibitors: findings with up to five years of treatment in the multicenter, randomized, double-blind, placebo-controlled, phase 3 GO-AFTER study
Enthalten in Arthritis Research & Therapy Bd. 17, 22.1.2015, Nr. 1, date:12.2015: 1-8
|
|
|
|
54 |
Goodbye to a great clinician, scientist and role model: Winfried Graninger (1956–2023)
Enthalten in Wiener klinische Wochenschrift Bd. 135, 9.8.2023, Nr. 15-16, date:8.2023: 441-442
|
|
|
|
55 |
Heterologous vector versus homologous mRNA COVID-19 booster vaccination in non-seroconverted immunosuppressed patients: a randomized controlled trial
Enthalten in Nature Communications Bd. 13, 12.9.2022, Nr. 1, date:12.2022: 1-9
|
|
|
|
56 |
Imbalance of local bone metabolism in inflammatory arthritis and its reversal upon tumor necrosis factor blockade: direct analysis of bone turnover in murine arthritis
Enthalten in Arthritis Research & Therapy Bd. 8, 30.12.2005, Nr. 1, date:2.2005: 1-11
|
|
|
|
57 |
Immunoadsorption as a rescue therapy in systemic lupus erythematosus: considerations on safety and efficacy
Enthalten in Wiener klinische Wochenschrift Bd. 116, 1.11.2004, Nr. 21-22, date:11.2004: 716-724
|
|
|
|
58 |
Impairment of chondrocyte biosynthetic activity by exposure to 3-tesla high-field magnetic resonance imaging is temporary
Enthalten in Arthritis Research & Therapy Bd. 8, 10.7.2006, Nr. 4, date:8.2006: 1-11
|
|
|
|
59 |
Improvement in patient-reported outcomes and work productivity following 3-year ustekinumab or tumour necrosis factor inhibitor treatment in patients with psoriatic arthritis: results from the PsABio real-world study
Enthalten in Arthritis Research & Therapy Bd. 25, 23.6.2023, Nr. 1, date:12.2023: 1-14
|
|
|
|
60 |
Infliximab: 12 years of experience
Enthalten in Arthritis Research & Therapy Bd. 13, 25.5.2011, Nr. 1, date:12.2011: 1-18
|
|
Administration
